The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This stock page is the Follow view. The Build view lets your agent query Hepion Pharmaceuticals, Inc. owners, fund changes, insider filings, and source links through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/HEPA"
Use Arkolith to show who owns Hepion Pharmaceuticals, Inc., which funds added or reduced it, and which SEC filings prove each claim.
Not held in any tracked 13F filing yet.
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Apr 21, 2026 | Appajosyula Sireesh | Director | Buy (P) | 1.3M | $50K |
| Apr 21, 2026 | LoPriore Vincent S | Executive Chairman, Director, 10% Owner | Buy (P) | 5.0M | $200K |
| Apr 21, 2026 | LoPriore Vincent S | Executive Chairman, Director, 10% Owner | Buy (P) | 1.3M | $50K |
| Apr 21, 2026 | Purcell Michael J. | Director | Buy (P) | 1.3M | $50K |
| Apr 21, 2026 | Stetz Gary S. | Interim CEO, Director | Buy (P) | 1.3M | $50K |
| Mar 6, 2024 | Purcell Michael J. | Director | Grant (A) | 50K | $0 |
| Feb 19, 2024 | JACOB GARY S | Director | Grant (A) | 85K | $0 |
| Feb 19, 2024 | BRANCACCIO JOHN P | Chairman, Director | Grant (A) | 85K | $0 |
| Feb 19, 2024 | Lbiati Kaouthar | Director | Grant (A) | 85K | $0 |
| Feb 19, 2024 | Block Timothy M. | Director | Grant (A) | 85K | $0 |
| Nov 27, 2023 | Wijngaard Peter | Director | Buy (P) | 3K | $8K |
| Nov 24, 2023 | Wijngaard Peter | Director | Buy (P) | 3K | $8K |
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for HEPA. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes. Every panel above is one call to the Arkolith API & MCP server.